MedPath

Evaluation of Breast MRI

Not Applicable
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2022/08/044637
Lead Sponsor
PtB D sharma PGIMS Rohtak
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with

Breast masses detected clinically or on ultrasound with BI-RADS staging �III.

Exclusion Criteria

� Post operative cases.

� Patients with no mass lesions with BIRADS � III finding on ultrasound or X-ray mammography.

� Contraindications to MRI imaging (metal debris, cardiacpace maker, claustrophobic patients etc).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of areas of malignant non mass enhancement in patient with suspected malignant breast lesions as diagnosed on mammogram and ultrasonography.Timepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
1. Evaluation of non mass enhancement <br/ ><br>Characterization of NME. <br/ ><br>Cytopathological correlation of the mass lesion as well as non enhancing lesions.Timepoint: 4 weeks
© Copyright 2025. All Rights Reserved by MedPath